An older adult client is receiving digoxin 0.25 mg PO every day, furosemide 40 mg PO twice a day, and potassium chloride 20 mEq PO twice a day. The client remarks, “What a lovely yellow uniform you are wearing today.” The practical nurse (PN) is wearing white. Which action should the PN implement?

Choice A reason: Recording blood pressures is relevant, as diazepam may cause hypotension, but it is less critical than respiratory monitoring. Status epilepticus requires rapid seizure control, and diazepam’s respiratory depression risk is more immediate, as it can lead to life-threatening hypoxia if not addressed promptly.

Choice B reason: Measuring urinary output monitors renal function but is not urgent in status epilepticus. Diazepam’s primary risk is respiratory depression, not renal effects. Ensuring airway and breathing stability is more critical, as seizures and the drug both threaten respiratory function, making this choice secondary.

Choice C reason: Monitoring respiratory rate and effort is critical, as diazepam, a CNS depressant, can cause respiratory depression, especially in status epilepticus, where seizures already compromise breathing. Hypoventilation risks hypoxia, potentially leading to brain damage or death, making this the most urgent intervention to ensure airway safety.

Choice D reason: Observing eye deviation may indicate ongoing seizures but is less urgent than respiratory monitoring. Diazepam controls seizures, but its side effect of respiratory depression poses an immediate threat. Ensuring adequate ventilation is the priority to prevent hypoxia during acute seizure management.

Choice A reason: Reassuring that neutropenia causes bone pain is incorrect, as the pain is a side effect of filgrastim, not neutropenia. Filgrastim stimulates bone marrow, causing medullary expansion and pain. Misattributing the cause fails to address the drug’s effect, making this choice inappropriate.

Choice B reason: Preparing a variance report is unnecessary, as bone pain is a known filgrastim side effect, not an error. Filgrastim increases neutrophil production, stressing bone marrow and causing pain. Reporting is not the priority; managing the client’s discomfort is more immediate and appropriate.

Choice C reason: Changing the injection site does not alleviate bone pain, as it results from filgrastim’s systemic effect on bone marrow stimulation, not local irritation. Pain is due to increased hematopoiesis in marrow, not the injection itself, making this choice ineffective for addressing the symptom.

Choice D reason: Offering a PRN analgesic addresses bone pain, a common filgrastim side effect caused by bone marrow expansion from stimulated neutrophil production. Analgesics relieve discomfort without altering the drug’s therapeutic effect, making this the most appropriate action to improve client comfort and adherence.